Evidence map›Paper›PMID 41149301›Full record

ArticleBiosensors2025

Cost-Effective and High-Throughput LPS Detection via Microdroplet Technology in Biopharmaceuticals.

Adriano Colombelli, Daniela Lospinoso, Valentina Arima, Vita Guarino, Alessandra Zizzari, Monica Bianco, Elisabetta Perrone, Luigi Carbone, Roberto Rella, Maria Grazia Manera

Abstract read
In one paragraph

Article in Biosensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Adriano ColombelliCNR NANOTEC-Institute of Nanotechnology, Campus Ecotekne, Via Monteroni, 73100 Lecce, Italy.ORCID 0000-0001-7840-9699
Daniela LospinosoCNR IMM-Institute for Microelectronics and Microsystems, Campus Ecotekne, Via Monteroni, 73100 Lecce, Italy.ORCID 0000-0001-6143-2040
Valentina ArimaCNR NANOTEC-Institute of Nanotechnology, Campus Ecotekne, Via Monteroni, 73100 Lecce, Italy.ORCID 0000-0002-3429-8365
Vita GuarinoCNR NANOTEC-Institute of Nanotechnology, Campus Ecotekne, Via Monteroni, 73100 Lecce, Italy.ORCID 0000-0001-6877-5169
Alessandra ZizzariCNR NANOTEC-Institute of Nanotechnology, Campus Ecotekne, Via Monteroni, 73100 Lecce, Italy.ORCID 0000-0002-9651-7922
Monica BiancoCNR NANOTEC-Institute of Nanotechnology, Campus Ecotekne, Via Monteroni, 73100 Lecce, Italy.ORCID 0000-0002-1791-7232
Elisabetta PerroneCNR NANOTEC-Institute of Nanotechnology, Campus Ecotekne, Via Monteroni, 73100 Lecce, Italy.
Luigi CarboneCNR NANOTEC-Institute of Nanotechnology, Campus Ecotekne, Via Monteroni, 73100 Lecce, Italy.ORCID 0000-0002-1369-6890
Roberto RellaCNR IMM-Institute for Microelectronics and Microsystems, Campus Ecotekne, Via Monteroni, 73100 Lecce, Italy.ORCID 0000-0002-9696-1476
Maria Grazia ManeraCNR IMM-Institute for Microelectronics and Microsystems, Campus Ecotekne, Via Monteroni, 73100 Lecce, Italy.ORCID 0000-0001-9718-2530

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipopolysaccharides (LPS) from Gram-negative bacteria represent a significant challenge across various industries due to their prevalence and pathogenicity and the limitations of existing detection methods. Traditional approaches, such as the rabbit pyrogen test (RPT) and the Limulus Amebocyte Lysate (LAL) assay, have served as gold standards for endotoxin detection. However, these methods are constrained by high costs, lengthy processing times, environmental concerns, and the need for significant reagent volumes, which limit their scalability and application in resource-limited settings. In this study, we introduce an innovative microfluidic platform that integrates the LAL assay within microdroplets, addressing the critical limitations of traditional techniques. By leveraging the precise fluid control and reaction isolation offered by microdroplet technology, the system reduces reagent consumption, enhances sensitivity, and enables high-throughput analysis. Calibration tests were performed to validate the platform's ability to detect LPS, using colorimetric measurements. Results demonstrated comparable or improved performance relative to traditional systems, achieving lower detection limits and greater accuracy. This work demonstrates a proof-of-concept miniaturisation of the pharmacopoeial LAL assay. The method yielded low intra-assay variability (σ ≈ 0.002 OD; CV ≈ 0.9% over n = 50 droplets per point) and a LOD estimated from calibration statistics after path-length normalisation. Broader adoption will require additional comparative validation and standardisation. This scalable, cost-effective, and environmentally sustainable approach offers a practical solution for endotoxin detection in clinical diagnostics, biopharmaceutical production, and environmental monitoring. The proposed technology paves the way for advanced LPS detection methods that meet stringent safety standards while improving efficiency, affordability, and adaptability for diverse applications.

Indexed as

Biosensing TechniquesLipopolysaccharidesAnimalsBiological ProductsCost-Benefit AnalysisHigh-Throughput Screening AssaysLimulus TestBiological ProductsLipopolysaccharidesbiosensingcolorimetric sensorsLAL testmicrodroplet generationmicrofluidics

Identifiers

PMID41149301
PMCPMC12564131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.